You are cordially invited to our next speaker event, by Sir Brian Heap, where he will be speaking on the topic of “Consumption and Happiness”.

Details:
Date: 24th of October 2007 (Wednesday)
Time: 4pm-6pm
Venue: Winstanley Lecture theatre, Trinity College

If you are attending this event, please email secretary@cuuna.org

There will be an opportunity to dine with our speaker after this event. Places are limited and given out on a first-come-first-served basis, with priority given to members. Please email secretary@cuuna.org to book your space, stating your dietary requirements.

Speaker: Sir Brian Heap

Brian Heap is Research Associate at the Capability and Sustainability Centre, St Edmund’s College, Cambridge, Editor of the Philosophical Transactions of the Royal Society (Biological Sciences), Special Professor at the University of Nottingham, Principle Scientific Adviser of ZyGEM Co Ltd New Zealand, President of the International Society of Science and Religion, Vice-President of European Academies Science Advisory Council, Chair of Academia Europaea Trustees, Board member of Sense about Science, and trustee of various other organizations. He holds doctorates from the Universities of Nottingham and Cambridge, has published in endocrine physiology, biotechnology, sustainable consumption and production, science advice and science policy issues, and was Master of St Edmund’s College, Cambridge. He was Vice-President and Foreign Secretary of the Royal Society, Director of Research at the Biotechnology and Biological Sciences Research Council, President of the Institute of Biology, UK Representative on the European Science Foundation, UK Representative on the NATO Science Committee, Chair of the Cambridge Genetics Knowledge Park, Advisory Board member of the Templeton Foundation USA, and a judge of the Templeton Prize. Sir Brian served on the Nuffield Council on Bioethics, the Department of Health’s Expert Group on Cloning, has worked on developing country issues particularly in China with the World Health Organisation, and was scientific consultant for Merck, Sharp and Dohme, Johnson and Johnson, and Ligand Pharmaceuticals in the USA.